NO20010490D0 - Inhibisjon av ''graft-versus-host''-sykdom - Google Patents
Inhibisjon av ''graft-versus-host''-sykdomInfo
- Publication number
- NO20010490D0 NO20010490D0 NO20010490A NO20010490A NO20010490D0 NO 20010490 D0 NO20010490 D0 NO 20010490D0 NO 20010490 A NO20010490 A NO 20010490A NO 20010490 A NO20010490 A NO 20010490A NO 20010490 D0 NO20010490 D0 NO 20010490D0
- Authority
- NO
- Norway
- Prior art keywords
- graft
- versus
- inhibition
- host
- disease
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4621—Cellular immunotherapy characterized by the effect or the function of the cells immunosuppressive or immunotolerising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/46434—Antigens related to induction of tolerance to non-self
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
- A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/02—Atmosphere, e.g. low oxygen conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2244554 CA2244554A1 (en) | 1998-07-30 | 1998-07-30 | Inhibition of graft versus host disease |
PCT/CA1999/000706 WO2000006703A2 (en) | 1998-07-30 | 1999-07-30 | Inhibition of graft versus host disease |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20010490D0 true NO20010490D0 (no) | 2001-01-29 |
NO20010490L NO20010490L (no) | 2001-03-29 |
Family
ID=4162727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20010490A NO20010490L (no) | 1998-07-30 | 2001-01-29 | Inhibisjon av ''graft-versus-host''-sykdom |
Country Status (16)
Country | Link |
---|---|
US (2) | US6258357B1 (no) |
EP (1) | EP1100875A2 (no) |
JP (1) | JP2002523332A (no) |
KR (1) | KR20010072095A (no) |
CN (1) | CN1314939A (no) |
AU (1) | AU755630B2 (no) |
BR (1) | BR9912594A (no) |
CA (1) | CA2244554A1 (no) |
CZ (1) | CZ2001316A3 (no) |
EA (1) | EA200100195A1 (no) |
IL (1) | IL141007A0 (no) |
MX (1) | MXPA01001144A (no) |
NO (1) | NO20010490L (no) |
NZ (1) | NZ509387A (no) |
WO (1) | WO2000006703A2 (no) |
ZA (1) | ZA200101614B (no) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE516133C2 (sv) * | 1999-02-25 | 2001-11-19 | Lundblad Leif J I | Användning av vissa substituerade indolokinoxaliner för framställning av ett medel för skydd av vävnader, organ och celler vid transplantation |
US8147824B2 (en) * | 1999-08-05 | 2012-04-03 | Athersys, Inc. | Immunomodulatory properties of multipotent adult progenitor cells and uses thereof |
CA2324199A1 (en) | 2000-10-25 | 2002-04-25 | Vasogen Ireland Limited | Chronic lymphocytic leukemia treatment |
SI1411918T1 (sl) * | 2001-07-31 | 2012-04-30 | Genzyme Global S A R L | Postopki za mobilizacijo progenitorskih/matičnih celic |
US7037900B2 (en) * | 2001-10-12 | 2006-05-02 | Supergen, Inc. | Composition and method for treating graft-versus-host disease |
US20050084967A1 (en) * | 2002-06-28 | 2005-04-21 | Xcyte Therapies, Inc. | Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation |
US20040175373A1 (en) * | 2002-06-28 | 2004-09-09 | Xcyte Therapies, Inc. | Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation |
ES2422193T3 (es) * | 2002-06-28 | 2013-09-09 | Life Technologies Corp | Métodos para restaurar el repertorio inmune en pacientes con defectos inmunológicos relacionados con la autoinmunidad y trasplante de órganos o de células madre hematopoyéticas |
WO2004094463A2 (en) * | 2003-04-18 | 2004-11-04 | University Of Florida Research Foundation, Inc. | Peptide inhibitors of autophosphorylation protein kinases |
WO2007011960A2 (en) * | 2005-07-18 | 2007-01-25 | Advanced Immune Biotechnologies, Inc. | Methods and agents to treat autoimmune diseases |
US20100196327A1 (en) * | 2007-04-11 | 2010-08-05 | Cell Science Systems | Methods for diagnosing biological samples containing stem cells |
AU2008331501B2 (en) * | 2007-11-30 | 2014-09-04 | New York Medical College | Methods of isolating non-senescent cardiac stem cells and uses thereof |
US8512696B2 (en) * | 2007-11-30 | 2013-08-20 | Autologous, Llc | Methods of isolating non-senescent cardiac stem cells and uses thereof |
EP2612907A1 (en) * | 2012-01-05 | 2013-07-10 | Taipei Veterans General Hospital | Preparation of cell transplant |
RU2508924C1 (ru) * | 2013-02-21 | 2014-03-10 | Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" | Способ профилактики и лечения отторжения почечного трансплантата |
JP7445946B2 (ja) * | 2019-06-12 | 2024-03-08 | 国立大学法人九州大学 | 性質変化方法及びプラズマ生成装置 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5980954A (en) * | 1992-02-07 | 1999-11-09 | Vasogen Ireland Limited | Treatment of autoimmune diseases |
EP0831860B1 (en) * | 1995-05-25 | 2004-10-20 | Baxter International Inc. | Allogeneic cell therapy for cancer following allogeneic stem cell transplantation |
ES2151095T3 (es) * | 1996-03-29 | 2000-12-16 | Procter & Gamble | Metodo para evaluar estructuras absorbentes desechables. |
-
1998
- 1998-07-30 CA CA 2244554 patent/CA2244554A1/en not_active Abandoned
-
1999
- 1999-07-30 US US09/363,678 patent/US6258357B1/en not_active Expired - Fee Related
- 1999-07-30 MX MXPA01001144A patent/MXPA01001144A/es unknown
- 1999-07-30 NZ NZ50938799A patent/NZ509387A/xx unknown
- 1999-07-30 IL IL14100799A patent/IL141007A0/xx unknown
- 1999-07-30 EP EP19990936202 patent/EP1100875A2/en not_active Withdrawn
- 1999-07-30 CN CN99810240A patent/CN1314939A/zh active Pending
- 1999-07-30 KR KR1020017001235A patent/KR20010072095A/ko not_active Application Discontinuation
- 1999-07-30 CZ CZ2001316A patent/CZ2001316A3/cs unknown
- 1999-07-30 AU AU51433/99A patent/AU755630B2/en not_active Ceased
- 1999-07-30 JP JP2000562485A patent/JP2002523332A/ja active Pending
- 1999-07-30 WO PCT/CA1999/000706 patent/WO2000006703A2/en active Search and Examination
- 1999-07-30 BR BR9912594A patent/BR9912594A/pt not_active IP Right Cessation
- 1999-07-30 EA EA200100195A patent/EA200100195A1/ru unknown
-
2001
- 2001-01-29 NO NO20010490A patent/NO20010490L/no not_active Application Discontinuation
- 2001-02-27 ZA ZA200101614A patent/ZA200101614B/en unknown
- 2001-05-14 US US09/853,755 patent/US20010028879A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU755630B2 (en) | 2002-12-19 |
EA200100195A1 (ru) | 2001-10-22 |
CZ2001316A3 (cs) | 2001-10-17 |
WO2000006703A3 (en) | 2000-05-04 |
CN1314939A (zh) | 2001-09-26 |
WO2000006703A2 (en) | 2000-02-10 |
US20010028879A1 (en) | 2001-10-11 |
AU5143399A (en) | 2000-02-21 |
EP1100875A2 (en) | 2001-05-23 |
CA2244554A1 (en) | 2000-01-30 |
KR20010072095A (ko) | 2001-07-31 |
NO20010490L (no) | 2001-03-29 |
JP2002523332A (ja) | 2002-07-30 |
US6258357B1 (en) | 2001-07-10 |
NZ509387A (en) | 2002-10-25 |
ZA200101614B (en) | 2002-01-02 |
IL141007A0 (en) | 2002-02-10 |
MXPA01001144A (es) | 2002-04-24 |
BR9912594A (pt) | 2002-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2018020I1 (el) | Θεραπεια της νοσου ρομρε | |
FR20C1039I2 (fr) | Derives de l'uk-2a | |
MA27126A1 (fr) | 3'PROMEDICAMENTS DE 2'-DESOXY- β-L-NUCLEOSIDES | |
DE60023268D1 (de) | INHIBITEURS PURIQUES DE KINASE 2 DEPENDANTE DES CYCLINES et IkB-alpha | |
EE200200716A (et) | Ühendid Alzheimeri tõve käitluseks | |
DZ2495A1 (fr) | Formule nouvelle de l'oméprazole-s. | |
NO20002686L (no) | Forbedring av Peyronies sykdom | |
MA26812A1 (fr) | Pyrimidine-2,4,6-triones inhibitrices de metalloproteinases | |
IL149592A0 (en) | Synthesis of 2'-deoxy-l-nucleosides | |
NO20010490D0 (no) | Inhibisjon av ''graft-versus-host''-sykdom | |
NO981388L (no) | Bedring av Dupuytrens sykdom | |
NO20010651D0 (no) | Inhibering av type 3 3<alfa>-hydroxysteroiddehydrogenase | |
FR2779192B1 (fr) | Accouplement d'arbres | |
TR199701051A3 (tr) | 2' -Fluoro-5-metil- -l-arabino-furanosilüridin hazirlanma prosesi | |
FR2802852B3 (fr) | Production d'elements figures | |
NO20016030L (no) | Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin | |
ATE243218T1 (de) | 2''-deoxyhygromycinderivate | |
NO20005856D0 (no) | Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner | |
UA2894S (uk) | Комплект етикеток "візит" | |
ITMI20000810A0 (it) | Procedimento per la preparazione di 5'-acetilstavudina | |
FR2810389B1 (fr) | Raccordement d'embouts | |
UA1629S (uk) | Набір фестонів "веснянка-5" | |
UA2593S (uk) | Комплект етикеток для гіркої настоянки "град чернігів" | |
UA2190S (uk) | Комплект етикеток "древньокиївська" | |
UA2780S (uk) | Комплект етикеток "древньокиївське" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |